A view of the future: Dr. Mark Gilbert of Immunex talks about immune based therapy. Interview by Robert Nielsen.
Gilbert
M
M
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D018664:Interleukin-12 / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use
D016915:AIDS Vaccines; D007376:Interleukin-2; D011994:Recombinant Proteins; D018664:Interleukin-12; C081222:sargramostim; D016178:Granulocyte-Macrophage Colony-Stimulating Factor